Organization
Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
5 abstracts
Abstract
Comparison of primary versus metastatic tumor tissue sources when designing panels for whole genome–based tumor-informed ctDNA assays in clear cell renal cell carcinoma.Org: Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, Myriad Genetics, Inc., Salt Lake City, UT,
Abstract
Racial and socioeconomic disparities in time to chemotherapy and survival in patients with pancreatic cancer.Org: Allegheny General Hospital, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Allegheny Health Network Cancer Institute, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumor.Org: Juntendo University School of Medicine, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Hiroshima University, National Cancer Center Hospital Japan East, Kashiwa, Japan, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
Survival outcomes of stage I small cell lung cancer (SCLC) treated with stereotactic body radiation therapy (SBRT) versus external beam radiation therapy (EBRT): An NCDB analysis.Org: University of Kentucky HealthCare, Markey Cancer Center, University of Kentucky, University of Kentucky, Lexington, KY, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
The influence of grade on mortality risk in salivary gland malignancy.Org: Cedars-Sinai Medical Center, Cedars-Sinai Medical Center Medical Genetics Prenatal Diagnosis Center, Cedars Sinai Medical Center, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,